Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 65 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

After a median follow-up time of 14.3 (7.9-20.0) years, dementia was recorded in 530 (1.2%) individuals with type 1 diabetes and 1,867 (0.9%) age-, sex-, and county-matched control individuals (mean baseline age 33.0 [14.0] years). Compared with control individuals, individuals with type 1 diabetes had a higher risk of all-cause dementia (hazard ratio [HR] 2.02 [95% CI 1.83-2.23], Alzheimer disease (HR 1.38 [95% CI 1.13-1.69]), vascular dementia (HR 3.73 [95% CI 3.07-4.52]) and non-Alzheimer-nonvascular dementia (HR 1.87 [95% CI 1.63-2.15]). Risk factors related to dementia risk in type 1 diabetes beyond age were lower education level, being single, higher systolic blood pressure, higher HbA1c, history of stroke or transient ischemic attack, history of cardiovascular disease, and longer diabetes duration. The risk of all-cause dementia and dementia subtypes is higher in individuals with type 1 diabetes compared with matched control individuals.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Jancev, M., Eliasson, B., Gerstein, H. C., Eeg‐Olofsson, K., Cukierman‐Yaffe, T., Biessels, G. J., et al. (2025). Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study. Diabetes Care. https://doi.org/10.2337/dc25-0773

Vancouver

Jancev M, Eliasson B, Gerstein HC, Eeg‐Olofsson K, Cukierman‐Yaffe T, Biessels GJ, et al. Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study. Diabetes Care. 2025. doi:10.2337/dc25-0773. PMID: 40970426.

BibTeX

@article{jancev2025-40970426,
  author  = {Jancev, Milena and Eliasson, Björn and Gerstein, Hertzel C. and Eeg‐Olofsson, Katarina and Cukierman‐Yaffe, Tali and Biessels, Geert Jan and DeVries, J. Hans and Visseren, Frank L.J. and others},
  title   = {{Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study}},
  journal = {Diabetes Care},
  year    = {2025},
  doi     = {10.2337/dc25-0773},
  pmid    = {40970426},
  url     = {https://doi.org/10.2337/dc25-0773}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This nationwide register-based cohort study found that people with type 1 diabetes had a higher risk of all-cause dementia, Alzheimer's disease, vascular dementia, and non-Alzheimer-nonvascular dementia compared with matched controls. Risk factors included lower education, being single, higher systolic blood pressure, higher HbA1c, history of stroke or transient ischemic attack, history of cardiovascular disease, and longer diabetes duration, but the study did not test treatments to prevent or cure dementia.

Study details

How this study scored 65/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 4 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 2 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 65 of 100.65 of 100 points earned35 not earned

Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Diabetes Care)
Journal's citation record 4 / 4 Diabetes Care: journal h-index 509 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 4 / 4 43,440 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 5 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.7 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 3.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Thomas T. van Sloten: h-index 34 (OpenAlex, whole career)
Institution's track record 2 / 3 University of Glasgow: institution h-index 1,600 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 11 institution(s) in 5 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40970426)
Free to read 2 / 2 Free to read
Total 65 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Risk factors

Also tagged “incidence”

1,084 studies in the library carry the topic tag “incidence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →